Global Deferiprone Market is expected to grow at a CAGR of 1.4% from 2020 to 2027

Deferiprone is an iron-chelating agent used in the treatment of iron overload associated with blood transfusion and non-transfusion-dependent thalassemia (NTDT). It is available as 500mg & 1000 mg film-coated tablets and 100mg/ml oral solution, which needs to be taken only under medical supervision to negate any possible outcome of drug-related adverse events. Transfusional iron overload […]